BIGBEAR
PHARMACEUTICALS
It is indicated for patients with specific types of prostate cancer and must be used in combination with a GnRH analog or in patients who have undergone bilateral orchiectomy.
AuthenticGuaranteeFast DeliveryPrivacy FDA Approval AnnouncementFebruary 14, 2018 -- The U.S. Food and Drug Administration today approved Erleada (apalutamide) for the treatment of patients···【Read More】
Update: 04 Mar,2026Source: Haiou HealthViews: 72
FDA Approval AnnouncementHORSHAM, Pa., Sept. 17, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today th···【Read More】
Update: 04 Mar,2026Source: Haiou HealthViews: 74
Copyright2024@ BIGBEAR All right reserved BIGBEAR
